In patients with cirrhosis and ascitic fluid, Juanola et al. (2016) identified how the role of regulatory T cells played for compensating the inflammatory environment in cirrhosis when norfloxacin was applied, and they found norfloxacin immunomodulatory effect on IL-2 and interferon γ reduction. Here, IL2 is linked to Cirrhosis.